Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index R

Radiation therapy: Sec. 3, Ch. 50
brain damage by: Sec. 3 Ch. 27 [sidebar]
in breast cancer: Sec. 3, Ch. 51; Sec. 3, Ch. 51
in chronic lymphocytic leukemia: Sec. 3, Ch. 51
in colorectal cancer: Sec. 3, Ch. 51
in head cancer: Sec. 3, Ch. 51
in lung cancer: Sec. 3, Ch. 51
in mouth cancer: Sec. 3, Ch. 51
in multiple myeloma: Sec. 3, Ch. 51
in neck cancer: Sec. 3, Ch. 51
in prostate cancer: Sec. 3, Ch. 51; Sec. 3, Ch. 51
in vulvar cancer: Sec. 3, Ch. 51
Radioactive iodine: Sec. 3, Ch. 33
Radiologist: Sec. 2, Ch. 9
Radionuclide scan
in coronary artery disease: Sec. 3, Ch. 45
for fracture: Sec. 3, Ch. 23
in prostate cancer: Sec. 3, Ch. 51
Raloxifene: Sec. 3, Ch. 22; Sec. 3, Ch. 22
Ramipril
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Range-of-motion exercise: Sec. 2, Ch. 13
after fracture treatment: Sec. 3, Ch. 23
after stroke: Sec. 2, Ch. 13
Ranitidine: Sec. 2, Ch. 6
Rash
in rosacea: Sec. 3, Ch. 35
in shingles: Sec. 3, Ch. 35
Reading
glasses for: Sec. 1, Ch. 2
light for: Sec. 1, Ch. 2; Sec. 1, Ch. 2; Sec. 3, Ch. 36
Receptors
in breast cancer: Sec. 2, Ch. 10; Sec. 3, Ch. 51; Sec. 3, Ch. 51
of nervous system: Sec. 1, Ch. 2
pain: Sec. 3 Ch. 24 [detail]
Recovery unit: Sec. 2, Ch. 12
Rectocele: Sec. 3, Ch. 58; Sec. 3, Ch. 58
Rectum
cancer of: (see also Colorectal cancer)
digital examination of
     in benign prostatic hyperplasia: Sec. 3, Ch. 59
     in prostate cancer: Sec. 3, Ch. 51
     in prostatitis: Sec. 3, Ch. 59
     in urinary incontinence: Sec. 3, Ch. 57
prolapse of (rectocele): Sec. 3, Ch. 58; Sec. 3, Ch. 58
Red blood cells: Sec. 3, Ch. 49
deficiency of: (see Anemia)
excess production of: Sec. 3, Ch. 49
     in COPD: Sec. 3, Ch. 53
hemoglobin of: Sec. 3, Ch. 49
production of: Sec. 3, Ch. 49
Red
perception of: Sec. 1, Ch. 2
Redundancy
in brain: Sec. 1, Ch. 2
Reflux
acid: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
with tube feeding: Sec. 3, Ch. 17
Refusal
informed: Sec. 4, Ch. 65
Regional anesthesia: Sec. 2, Ch. 12
Registered nurse: Sec. 2, Ch. 9
Regurgitation
aortic valve: Sec. 3, Ch. 48
of food: Sec. 3, Ch. 54
mitral valve: Sec. 3, Ch. 48; Sec. 3, Ch. 48
of stomach acid: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
Rehabilitation: Sec. 2, Ch. 13
at home: Sec. 2, Ch. 13
at nursing home: Sec. 2, Ch. 14
for blindness: Sec. 2, Ch. 13
duration of: Sec. 2, Ch. 9
after fracture treatment: Sec. 3, Ch. 23
goals of: Sec. 2, Ch. 13
for hearing loss: Sec. 2, Ch. 13
after heart attack: Sec. 3, Ch. 45; Sec. 3, Ch. 60
for heart disorders: Sec. 2, Ch. 13
after heart surgery: Sec. 3, Ch. 45
after hip replacement: Sec. 2, Ch. 13
inflammation treatment during: Sec. 2, Ch. 13
information resources on: 885-886
after leg amputation: Sec. 2, Ch. 13
occupational: Sec. 2, Ch. 13
outcome of: Sec. 2, Ch. 13
pain treatment during: Sec. 2, Ch. 13
physical: Sec. 2, Ch. 13
settings for: Sec. 2, Ch. 9
speech: Sec. 2, Ch. 13; Sec. 2, Ch. 13
after stroke: Sec. 2, Ch. 13; Sec. 3, Ch. 28; Sec. 3, Ch. 28
Relaxation training: Sec. 3, Ch. 24
Reliability
of test: Sec. 2, Ch. 10
Religion: Sec. 4, Ch. 61
Relocation
REM (rapid eye movement) sleep: Sec. 3 Ch. 31 [detail]
thrashing during: Sec. 3, Ch. 31
Renal scan: Sec. 2, Ch. 10
Repaglinide: Sec. 3, Ch. 34
Reproductive system
female: Sec. 3, Ch. 58
Reserpine: Sec. 2, Ch. 6
Resiliency: Sec. 4 Ch. 61 [sidebar]
Resources for health information: 881-889
Respiration
bed rest effects on: Sec. 2, Ch. 11
Respiratory infections: Sec. 3, Ch. 52
Respiratory syncytial virus infection: Sec. 3, Ch. 52; Sec. 3, Ch. 52
Rest home (board-and-care facility): Sec. 2, Ch. 14; Sec. 2, Ch. 14
Resting tremor: Sec. 3 Ch. 30 [sidebar]
Restless legs syndrome: Sec. 3, Ch. 31
Restlessness: Sec. 3, Ch. 30
Restraints
in delirium: Sec. 3, Ch. 26
use of: Sec. 2, Ch. 11
Reteplase: Sec. 3, Ch. 45
Retina
detachment of: Sec. 3, Ch. 36
in diabetes: Sec. 3, Ch. 36
emboli of: Sec. 3, Ch. 36
light sensitivity of: Sec. 1, Ch. 2; Sec. 1, Ch. 2
macular degeneration of: Sec. 3, Ch. 36
     dizziness and: Sec. 3, Ch. 20
tears of: Sec. 3, Ch. 36
Retinal artery
blockage of: Sec. 3, Ch. 36
Retinal vein
blockage of: Sec. 3, Ch. 36
Retinol: (see Vitamin A [retinol])
Retinopathy
diabetic: Sec. 3, Ch. 36
Retired and Senior Volunteer Program: Sec. 4, Ch. 61
Retirement community: Sec. 1, Ch. 3; Sec. 2, Ch. 14; Sec. 2, Ch. 14
Retirement: Sec. 4, Ch. 61
Reverse isolation: Sec. 2, Ch. 11
Rheumatic fever: Sec. 3, Ch. 48; Sec. 3, Ch. 48
Rheumatism: (see also Arthritis)
Rheumatoid arthritis: Sec. 3, Ch. 41
exercise in: Sec. 3, Ch. 60
undernutrition and: Sec. 3 Ch. 17 [detail]
Rheumatologist: Sec. 2, Ch. 9
Rhinitis: Sec. 3, Ch. 38
Rhinophyma: Sec. 3, Ch. 35
Rimantadine: Sec. 3, Ch. 52
in influenza: Sec. 3, Ch. 52
Ringing
in ears (tinnitus): Sec. 3, Ch. 37
Rings
esophageal: Sec. 3, Ch. 54
Risedronate: Sec. 3, Ch. 22
Risk profile: Sec. 2, Ch. 4
Risperidone: Sec. 3, Ch. 32
urinary incontinence with: Sec. 3, Ch. 57
Ritonavir
St. John's wort interaction with: Sec. 2, Ch. 7
Rivastigmine: Sec. 3, Ch. 27
Romance: Sec. 4, Ch. 63
Ropinirole: Sec. 3, Ch. 30; Sec. 3, Ch. 30
Rosacea: Sec. 3, Ch. 35; Sec. 3, Ch. 35
Rosiglitazone: Sec. 3, Ch. 34
Rosuvastatin: Sec. 3, Ch. 44
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.